Low-power extracorporeal shock wave therapy for suppression of renal function reduction in diabetic kidney disease patients diagnosed as chronic kidney disease (CKD) stage 3

Low-power extracorporeal shock wave therapy for suppression of renal function reduction in diabetic kidney disease patients diagnosed as chronic kidney disease (CKD) stage 3 - ESWT-DKD

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000030768

Enrollment

Registered

2018-01-12

Start date

2014-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic kidney disease patients

Interventions

Extracorporeal Shock Wave

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: CKD stage 3 type 2 diabetic kidney disease patients

Exclusion criteria

Exclusion criteria: Patients with bleeding tendency Patients with urolithiasis or kidney stones Patients with hydronephrosis Patients with active pyelonephritis Patients with cancer Objects considered by the attending physician as inappropriate

Design outcomes

Primary

Measure	Time frame
safety	—

Countries

Japan

Contacts

Public ContactYoshitaka Isaka

Osaka University Graduate School of Medicine Nephrology

isaka@kid.med.osaka-u.ac.jp0668793857

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026